U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07024797) titled 'Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese Participants' on June 09.

Brief Summary: This study will assess the adverse events, tolerability, and how oral doses of ABBV-932 moves through the body in healthy adult Chinese participants.

Study Start Date: Aug. 18

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: ABBV-932

Oral Capsule

DRUG: Placebo for ABBV-932

Oral Capsule

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AbbVie

Published by HT Digital Content Services with permission from Health Daily Digest....